Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs SkinnyRx

CoreAge Rx
Graded #1

Higher grade

vs+31.299999999999997
SkinnyRx
Graded #247

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 60.5/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +40
92
52
Dose & formulationEven
88
88
Clinical oversightCoreAge Rx +38
93
55
Labs & monitoringCoreAge Rx +50
90
40
FulfillmentCoreAge Rx +13
95
82
Contract termsCoreAge Rx +58
96
38
CoreAge Rx · left barSkinnyRx · right bar

The numbers

MetricCoreAge RxSkinnyRx
WeighScore91.8/10060.5/100
GradeA−C
Scorecard rank#1#247
Semaglutide$149/mo$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
Tirzepatide$349/mo$399/mo month-to-month (compounded; the advertised rate is a 12-month prepay)
CoverageAll 50 states47 states + DC (not Alabama, Louisiana or Mississippi)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
SkinnyRx

Graded #247 · C

FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.

Strengths

  • Both molecules by both routes: semaglutide and tirzepatide as injections, tirzepatide as a tablet on the identical term ladder, plus a separate low-dose line with its own page
  • The full term ladder — every rung, both molecules — is on the product page before any medical intake, which is more than most of this board discloses after one
  • Terms are concrete rather than gestural: free shipping, unlimited provider messaging, a 90-day money-back guarantee, and no charge at all if a clinician finds you ineligible
  • The state exclusions are published rather than discovered at checkout — 47 states plus DC, with Alabama, Louisiana and Mississippi named

Where it loses points

  • FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026; the letter is public in FDA's warning-letter database
  • The advertised "$199/mo" and "$299/mo" are twelve-month rates by construction — the site's own price code drops the one-month rung before picking a headline — so the monthly rates are $349 semaglutide and $399 tirzepatide
  • Those rungs are a single up-front charge, not a smaller bill: $2,388 for the semaglutide year and $3,588 for the tirzepatide year, taken on day one and auto-renewing each term, with membership fees stated as non-refundable
  • The microdose line costs the SAME as full dose at every term the two share, and its floor is HIGHER — $229 against $199 on semaglutide, $319 against $299 on tirzepatide — because the low-dose plans stop at eight months rather than twelve
  • No brand-name product is actually purchasable: Ozempic, Wegovy, Mounjaro and Zepbound all carry a null price, both pill products are out of stock, and the only priced brand path is a $49/mo membership plus a medication cost that is never published
  • Compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents of the brand drugs
  • Fulfillment is disclosed only as a category: "503A pharmacies", never a facility, never a city, and no medical director is named for the programme anywhere on the site — so the two things that decide whether a compounded vial is trustworthy are the two things this seller does not publish
  • Labs and monitoring are simply absent from the site: nothing states whether baseline or follow-up bloodwork is required, included in the membership, or billed on top of it
  • Alabama, Louisiana and Mississippi are excluded, so three states' readers cannot buy at any price on this ladder

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard